Literature DB >> 25864488

Genome-wide differentially methylated genes in prostate cancer tissues from African-American and Caucasian men.

J M Devaney1, S Wang, P Furbert-Harris, V Apprey, M Ittmann, B-D Wang, J Olender, N H Lee, B Kwabi-Addo.   

Abstract

Increasing evidence suggests that aberrant DNA methylation changes may contribute to prostate cancer (PCa) ethnic disparity. To comprehensively identify DNA methylation alterations in PCa disparity, we used the Illumina 450K methylation platform to interrogate the methylation status of 485,577 CpG sites focusing on gene-associated regions of the human genome. Genomic DNA from African-American (AA; 7 normal and 3 cancers) and Caucasian (Cau; 8 normal and 3 cancers) was used in the analysis. Hierarchical clustering analysis identified probe-sets unique to AA and Cau samples, as well as common to both. We selected 25 promoter-associated novel CpG sites most differentially methylated by race (fold change > 1.5-fold; adjusted P < 0.05) and compared the β-value of these sites provided by the Illumina, Inc. array with quantitative methylation obtained by pyrosequencing in 7 prostate cell lines. We found very good concordance of the methylation levels between β-value and pyrosequencing. Gene expression analysis using qRT-PCR in a subset of 8 genes after treatment with 5-aza-2'-deoxycytidine and/or trichostatin showed up-regulation of gene expression in PCa cells. Quantitative analysis of 4 genes, SNRPN, SHANK2, MST1R, and ABCG5, in matched normal and PCa tissues derived from AA and Cau PCa patients demonstrated differential promoter methylation and concomitant differences in mRNA expression in prostate tissues from AA vs. Cau. Regression analysis in normal and PCa tissues as a function of race showed significantly higher methylation prevalence for SNRPN (P = 0.012), MST1R (P = 0.038), and ABCG5 (P < 0.0002) for AA vs. Cau samples. We selected the ABCG5 and SNRPN genes and verified their biological functions by Western blot analysis and siRNA gene knockout effects on cell proliferation and invasion in 4 PCa cell lines (2 AA and 2 Cau patients-derived lines). Knockdown of either ABCG5 or SNRPN resulted in a significant decrease in both invasion and proliferation in Cau PCa cell lines but we did not observe these remarkable loss-of-function effects in AA PCa cell lines. Our study demonstrates how differential genome-wide DNA methylation levels influence gene expression and biological functions in AA and Cau PCa.

Entities:  

Keywords:  genome-wide DNA methylation analysis; prostate cancer; pyrosequencing

Mesh:

Substances:

Year:  2015        PMID: 25864488      PMCID: PMC4622564          DOI: 10.1080/15592294.2015.1022019

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  39 in total

Review 1.  Abnormal DNA methylation, epigenetics, and prostate cancer.

Authors:  William G Nelson; Srinivasan Yegnasubramanian; Agoston T Agoston; Patrick J Bastian; Byron H Lee; Masashi Nakayama; Angelo M De Marzo
Journal:  Front Biosci       Date:  2007-05-01

2.  Differential expression of stem cell markers and ABCG2 in recurrent prostate cancer.

Authors:  Esra Guzel; Omer F Karatas; Mehmet B Duz; Mustafa Solak; Michael Ittmann; Mustafa Ozen
Journal:  Prostate       Date:  2014-08-29       Impact factor: 4.104

3.  Alterations in the p53 and MDM-2 genes are infrequent in clinically localized, stage B prostate adenocarcinomas.

Authors:  M Ittmann; R Wieczorek; P Heller; A Dave; J Provet; J Krolewski
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

4.  Cellular differentiation, cytidine analogs and DNA methylation.

Authors:  P A Jones; S M Taylor
Journal:  Cell       Date:  1980-05       Impact factor: 41.582

5.  Deregulation of an imprinted gene network in prostate cancer.

Authors:  Teodora Ribarska; Wolfgang Goering; Johanna Droop; Klaus-Marius Bastian; Marc Ingenwerth; Wolfgang A Schulz
Journal:  Epigenetics       Date:  2014-02-10       Impact factor: 4.528

6.  Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia.

Authors:  J M Devaney; S Wang; S Funda; J Long; D J Taghipour; R Tbaishat; P Furbert-Harris; M Ittmann; B Kwabi-Addo
Journal:  Prostate Cancer Prostatic Dis       Date:  2013-07-30       Impact factor: 5.554

7.  Maternal imprinting of human SNRPN, a gene deleted in Prader-Willi syndrome.

Authors:  M L Reed; S E Leff
Journal:  Nat Genet       Date:  1994-02       Impact factor: 38.330

8.  Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer.

Authors:  Nathaniel Polnaszek; Bernard Kwabi-Addo; Leif E Peterson; Mustafa Ozen; Norman M Greenberg; Sagrario Ortega; Claudio Basilico; Michael Ittmann
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

9.  Age-related DNA methylation changes in normal human prostate tissues.

Authors:  Bernard Kwabi-Addo; Woonbok Chung; Lanlan Shen; Michael Ittmann; Thomas Wheeler; Jaroslav Jelinek; Jean-Pierre J Issa
Journal:  Clin Cancer Res       Date:  2007-07-01       Impact factor: 12.531

10.  Isolation and genome-wide expression and methylation characterization of CD31+ cells from normal and malignant human prostate tissue.

Authors:  Wei Luo; Qiang Hu; Dan Wang; Kristin K Deeb; Yingyu Ma; Carl D Morrison; Song Liu; Candace S Johnson; Donald L Trump
Journal:  Oncotarget       Date:  2013-09
View more
  27 in total

Review 1.  Molecular mechanisms involving prostate cancer racial disparity.

Authors:  Cansu Karakas; Cassie Wang; Fangming Deng; Hongying Huang; Dongwen Wang; Peng Lee
Journal:  Am J Clin Exp Urol       Date:  2017-11-09

2.  DNA methylation profiles in African American prostate cancer patients in relation to disease progression.

Authors:  Rohina Rubicz; Shanshan Zhao; Milan Geybels; Jonathan L Wright; Suzanne Kolb; Brandy Klotzle; Marina Bibikova; Dean Troyer; Raymond Lance; Elaine A Ostrander; Ziding Feng; Jian-Bing Fan; Janet L Stanford
Journal:  Genomics       Date:  2016-02-21       Impact factor: 5.736

Review 3.  Racial Differences in Cancer Susceptibility and Survival: More Than the Color of the Skin?

Authors:  Berna C Özdemir; Gian-Paolo Dotto
Journal:  Trends Cancer       Date:  2017-03-06

Review 4.  Epigenetic basis of cancer health disparities: Looking beyond genetic differences.

Authors:  Aamir Ahmad; Shafquat Azim; Haseeb Zubair; Mohammad Aslam Khan; Seema Singh; James E Carter; Rodney P Rocconi; Ajay P Singh
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-01-17       Impact factor: 10.680

Review 5.  African-American Prostate Cancer Disparities.

Authors:  Zachary L Smith; Scott E Eggener; Adam B Murphy
Journal:  Curr Urol Rep       Date:  2017-08-14       Impact factor: 3.092

Review 6.  Role of Alternative Splicing in Prostate Cancer Aggressiveness and Drug Resistance in African Americans.

Authors:  Jacqueline Olender; Norman H Lee
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 7.  Analysis of Tumor Biology to Advance Cancer Health Disparity Research.

Authors:  Cheryl J Smith; Tsion Z Minas; Stefan Ambs
Journal:  Am J Pathol       Date:  2017-11-11       Impact factor: 4.307

8.  Epigenetic analysis identifies factors driving racial disparity in prostate cancer.

Authors:  Richa Rai; Shalini S Yadav; Heng Pan; Irtaza Khan; James O'Connor; Mohammed Alshalalfa; Elai Davicioni; Emanuela Taioli; Olivier Elemento; Ashutosh K Tewari; Kamlesh K Yadav
Journal:  Cancer Rep (Hoboken)       Date:  2018-12-13

9.  Ethnic differences in TGFβ-signaling pathway may contribute to prostate cancer health disparity.

Authors:  Bethtrice Elliott; DeAdra L Zackery; Vanessa A Eaton; Re'Josef T Jones; Fisseha Abebe; Camille C Ragin; Shafiq A Khan
Journal:  Carcinogenesis       Date:  2018-04-05       Impact factor: 4.944

10.  Race Does Not Affect Tumor Control, Adverse Effects, or Quality of Life after Proton Therapy.

Authors:  Curtis Bryant; Bradford S Hoppe; Randal H Henderson; Romaine C Nichols; William M Mendenhall; Tamara L Smith; Christopher G Morris; Christopher R Williams; Zhong Su; Zuofeng Li; Nancy P Mendenhall
Journal:  Int J Part Ther       Date:  2017-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.